New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 11, 2014
10:01 EDTTMO, OMED, VSTM, HLT, MTD, SNAK, T, AHPOn The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: AT&T (T) initiated with a Buy at Drexel Hamilton... Ashford Hospitality Prime (AHP) initiated with a Buy at SunTrust... Cypress Energy (CELP) initiated with an Outperform at Raymond James... Hilton Worldwide (HLT) initiated with a Positive at Susquehanna... OncoMed (OMED) initiated with a Buy at Mizuho... RSP Permian (RSPP) initiated with an Overweight at Barclays... The Inventure Group (SNAK) initiated with an Outperform at Wedbush... Verastem (VSTM) initiated with a Buy at Mizuho... Xilinx (XLNX) initiated with a Buy at MKM Partners... RSP Permian (RSPP) initiated with an Outperform at Raymond James... Thermo Fisher (TMO) resumed with an Overweight at JPMorgan... Mettler-Toledo (MTD) initiated with a Market Perform at Wells Fargo.
News For T;AHP;HLT;OMED;SNAK;VSTM;TMO;MTD From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 >>
August 27, 2015
11:25 EDTTSamsung Pay beta available on all U.S. carriers except Verizon, Verge reports
Samsung (SSNLF) Pay's beta is available on all major U.S. carriers, including AT&T (T), Sprint (S), T-Mobile (TMUS), and U.S. Cellular (USM), except for Verizon (VZ), the Verge reports. Verizon is "evaluating" Samsung Pay currently, and may very well miss the September 28th launch of the product, the report says. Reference Link
08:28 EDTVSTMVerastem weakness overdone, says JMP Securities
After Verastem reported that 24% of the KRAS-mutated NSCLC patients in a study of its FAK inhibitor defactinib had experienced serious adverse events, JMP Securities notes that it did not ascribe any valuation for the drug as a treatment for this indication. Moreover, the firm does not believe that the study affects the outlook for the drug in other settings, and it says that, given the patients' late stage status, deaths among the participants "would not be seen as an anamoly." JMP adds that the drug met its primary endpoint in the study. JMP reiterates a $23 price target and Outperform rating on the shares.
August 26, 2015
16:26 EDTVSTMOn The Fly: Top stock stories for Wednesday
Subscribe for More Information
15:16 EDTVSTMVerastem says VS-6063 results under embargo, believes study has met goals
Verastem issued the following statement in response to inquiries regarding the anticipated oral presentation of VS-6063 data from a Phase 2 study in patients with KRAS mutant non-small cell lung cancer, or NSCLC, at the 16th World Conference on Lung Cancer: "While updated results from the Phase 2 study of VS-6063 in KRAS mutant non-small cell lung cancer are under embargo until WCLC, Verastem believes the study has met its goals, with encouraging outcomes that the company plans to explore in future studies. The population explored in this study has refractory, advanced lung cancer, with a median of three prior therapies, and as many as eight prior therapies. The advanced stage of disease led, in some cases, to deaths even in the period between screening and prior to first dose of VS-6063. Two subjects reported as having grade 5 respiratory failure were on multiple concomitant medications and presented with multiple co-morbidities. Both were thoroughly evaluated and reported to the regulatory authorities in 2013 and 2014 when they occurred. The totality of safety and efficacy data seen to date with VS-6063 across multiple clinical trials, multiple tumor types and stages of treatment is promising. In addition, in the company's registration-directed COMMAND trial in mesothelioma, an independent data safety monitoring board has met and reviewed study data, including adverse events, three times and recommended no changes to study protocol. There have been over 300 patients treated to date with VS-6063, including patients on drug for more than one year. Verastem remains encouraged by the clinical potential of targeting cancer stem cells through FAK inhibition, and is unwavering in its commitment to delivering novel, safe and effective treatments to patients with unmet medical needs."
13:45 EDTTAT&T ends airport Wi-Fi ads experiment, Re/code reports
AT&T has ended serving ads to consumers using its free Wi-Fi at two Washington, D.C.-area airports, Re/code reports. The company told Re/code that it was conducting an experiment of "an ongoing effort to explore alternate ways to deliver a free Wi-Fi service that is safe, secure and fast." Reference Link
12:30 EDTTAT&T may need to choose between dividend and credit rating, CTFN reports
AT&T, despite acquiring DirecTV, may have to choose between maintaining its credit rating and its dividend in a few years as web video displaces satellite, CTFN reports, citing two credit analysts and a senior executive. AT&T has reduced the pressure from high dividend payments after the DirecTV purchase, but "it could be back in the same situation within three years if DirecTV's cash flow isn't sustainable," according to Mark Stodden, VP and senior credit officer at Moody's. AT&T spokesperson said that any suggestion that it needs to reduce its dividend "ignores the facts," the report says. Reference Link
11:55 EDTVSTMVerastem safety concerns on NSCLC data misplaced, says Mizuho
Subscribe for More Information
11:43 EDTVSTMVerastem selloff on 'placeholder' abstract ignores key driver, says Roth Capital
Subscribe for More Information
10:51 EDTVSTMVerastem shares defended at Roth Capital
Subscribe for More Information
09:24 EDTVSTMVerastem to present data at World Conference on Lung Cancer
Subscribe for More Information
August 25, 2015
06:25 EDTTAT&T to rebrand services in Mexico, WSJ reports
Subscribe for More Information
August 24, 2015
16:00 EDTTOptions Update; August 24, 2015
Subscribe for More Information
August 23, 2015
19:13 EDTTBT executive says Verizon, AT&T abusing landline duopoly, FT reports
In a Financial Times interview published Sunday, BT Group's (BT) Americas president Bas Burger said Verizon (VZ) and AT&T (T) are abusing their control over telephone and broadband lines to charge inappropriate access fees to companies like BT. "For a western world country it is the worst I've seen... There is not sufficient regulation to create competition: almost all access is being provided by two companies and they have divided the country among themselves," remarked Burger, adding that the two companies are also not required to fix network problems within any specific timeframe. Reference Link
August 20, 2015
08:02 EDTTFCC to hold a conference and workshop
2015 Supplier Diversity Conference & Workshop is being held at FCC Washington, D.C. offices on August 20 at 9:30 am. Webcast Link
05:48 EDTVSTM, OMEDMizuho keeps TESARO, Verastem, OncoMed as top biotech picks
Subscribe for More Information
August 19, 2015
10:20 EDTTBig telecom firms put M&A on hold, CTFN reports
Subscribe for More Information
08:22 EDTTSprint traffic levels increasing, says Pacific Crest
Subscribe for More Information
August 18, 2015
11:34 EDTTSprint rises on plans to abandon two-year contracts
Sprint shares are higher this morning after the company's chief executive officer said that the carrier plans to move away from two-year contracts. WHAT'S NEW: In an interview with The Wall Street Journal, Sprint CEO Marcelo Claure said that the company will stop offering two-year contracts by the end of 2015 in favor of a "smartphone lease" model. Sprint began offering a lease option last year, The Journal noted, and Claure said the carrier is planning to move entirely to that model by the end of the year. As part of its shift, Sprint yesterday unveiled iPhone Forever, a new leasing plan that starts at $22 per month for an iPhone. WHAT'S NOTABLE: In a similar move earlier this month, Sprint rival Verizon (VZ) said it would drop phone subsidies and two-year contracts for new customers. T-Mobile (TMUS), another market rival, abandoned contracts over two years ago, leaving AT&T (T) as the only major U.S. carrier still offering to subsidize new smartphone purchases. Separately, Softbank (SFTBF), Sprint's primary stakeholder, disclosed last week that it increased its holdings in the company to approximately 80%, though the company said it does not plan for its stake in the carrier to exceed 85%. Meanwhile, a study released Tuesday by RootMetrics, an independent company that evaluates wireless networks, shows that Sprint is improving its network, having solidified third place nationally in overall performance, surpassing T-Mobile for the second consecutive six-month stretch. PRICE ACTION: Sprint is up 7c, or 1.52%, to $4.67 in morning trading.
August 17, 2015
06:26 EDTTAmerica Movil removes charges on U.S. calls for Mexican clients, Reuters says
Subscribe for More Information
06:17 EDTTAT&T aided NSA in web surveillance, NYT reports
The National Security Agency's, or NSA, ability to spy on great amounts of internet traffic has relied on a decades-long partnership with AT&T, the New York Times reports, citing newly disclosed NSA documents. The company's cooperation with the NSA has involved a broad range of activities from 2003-2013, including giving the NSA access to billions of emails and providing technical assistance in carrying out a secret court order permitting the wiretapping of all web communications at the UN headquarters, the report says. AT&T installed surveillance equipment in "at least" 17 of its U.S. internet hubs, the report says. Reference Link
1 | 2 >>

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use